American Psychiatric Association (1980) Diagnostic and Statistical Manual of Mental Disorders (3rd edn) (DSM–III). Washington, DC: APA.
American Psychiatric Association (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM–III–R). Washington, DC: APA.
American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn) (DSM–IV). Washington, DC: APA.
Andrews, G. (1993) The essential psychotherapies. British Journal of Psychiatry, 162, 447–451.
Andrews, G. & Jenkins, R., (eds) (1999) The Management of Mental Disorders. London: World Health Organization Collaborating Centre in Mental Health.
Sanderson, K., Slade, T., et al (2000) Why does the burden of disease persist? Relating the burden of anxiety and depression to effectiveness of treatment. Bulletin of the World Health Organization, 78, 446–454.
Cochrane, A. L. (1989) Effectiveness and Efficiency: Random Reflections on Health Services. London: British Medical Journal.
Enserink, M. (1999) Can the placebo be the cure?
Science, 284, 238–240.
Joffe, R., Sokolov, S. & Streiner, D. (1996) Antidepressant treatment of depression: a meta-analysis. Canadian Journal of Psychiatry, 41, 613–616.
Jorm, A. F., Angermeyer, M. & Katschnig, H. (2000) Public knowledge of and attitudes to mental disorders: a limiting factor in the optimal use of treatment services. In Unmet Need in Psychiatry (eds Andrews, G. & Henderson, A.), pp. 399–416. Cambridge: Cambridge University Press.
Kendler, K. S., Walters, E. E. & Kessler, R. C. (1997) The prediction of length of major depressive episodes: results from an epidemiological survey of female twins. Psychological Medicine, 27, 107–117.
Khan, A., Warner, H. A. & Brown, W. A. (2000) Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials. Archives of General Psychiatry, 57, 311–330.
Kraemer, H. C. (2000) Statistical analysis to settle ethical issues?
Archives of General Psychiatry, 57, 327–328.
McLeod, J. D., Kessler, R. C. & Land is, K. R. (1992) Speed of recovery from major depressive episodes in a community sample of married men and women. Journal of Abnormal Psychology, 101, 277–286.
Moncrieff, J., Wessely, S. & Hardy, R. (1998) Meta-analysis of trials comparing antidepressants with active placebos. British Journal of Psychiatry, 172, 227–231.
Murray, C. J. L. & Lopez, A. D. (1996) Global Burden of Disease. Cambridge, MA: Harvard University Press.
Mynors-Wallis, L. M., Gath, D. H., Lloyd-Thomas, A. R., et al (1995) Randomised controlled trial comparing problem solving treatment with amitriptyline and placebo for major depression in primary care. British Medical Journal. 310, 441–445.
Quality Assurance Project (1982) A treatment outline for agoraphobia. Australian and New Zealand Journal of Psychiatry, 16, 25–33.
Quality Assurance Project (1983) A treatment outline for depressive disorders. Australian and New Zealand Journal of Psychiatry, 17, 129–146.
Quality Assurance Project (1984) A treatment outline for the management of schizophrenia. Australian and New Zealand Journal of Psychiatry, 18, 19–38.
Quality Assurance Project (1985a) Treatment outlines for the management of anxiety states. Australian and New Zealand Journal of Psychiatry, 19, 138–151.
Quality Assurance Project (1985b) Treatment outlines for the management of obsessive–compulsive disorders. Australian and New Zealand Journal of Psychiatry, 19, 240–253.
Quitkin, F. M., Rabkin, J. G., Gerald, J., et al (2000) Validity of clinical trials of antidepressants. American Journal of Psychiatry, 157, 327–337.
Thase, M. E. (1999) How should efficacy be evaluated in randomized clinical trials of treatments for depression?
Journal of Clinical Psychiatry, 60 (suppl. 4): 23–31.
World Health Organization (1992) International Classification of Diseases and Related Disorders (ICD–10). Geneva: World Health Organization.